Lupin shifting bulk drugs production from Japan
In a bid to be competitive in the world's second largest pharma market, Mumbai-based drugmaker Lupin Ltd will soon be shifting the manufacturing base for its Japanese subsidiary Kyowa Pharma to Goa, thus, rationalising costs by over 25-30 per cent.
